FdaApplication
NDA 009175
Identifiers
- fda_app_no: NDA009175
Properties
| Property | Value |
|---|---|
| applicant_name | CASPER PHARMA LLC |
| application_type | NDA |
| approval_date | 2023-06-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FURADANTIN | NITROFURANTOIN | 50MG/5ML | SUSPENSION;ORAL |
| FURADANTIN | NITROFURANTOIN | 25MG/5ML | SUSPENSION;ORAL |
2 products